DENTSPLY SIRONA Inc (NASDAQ:XRAY) has been given an average recommendation of “Hold” by the sixteen research firms that are currently covering the stock, Marketbeat Ratings reports. Two analysts have rated the stock with a sell recommendation, four have given a hold recommendation and nine have assigned a buy recommendation to the company. The average 1 year target price among brokerages that have covered the stock in the last year is $68.92.

A number of research analysts have recently commented on XRAY shares. HC Wainwright reiterated a “buy” rating and issued a $68.00 price objective on shares of DENTSPLY SIRONA in a report on Tuesday, October 3rd. Cleveland Research downgraded DENTSPLY SIRONA from a “buy” rating to a “neutral” rating in a report on Thursday, October 5th. Morgan Stanley reiterated an “overweight” rating and issued a $69.00 price objective (up previously from $67.00) on shares of DENTSPLY SIRONA in a report on Friday, October 6th. Zacks Investment Research upgraded DENTSPLY SIRONA from a “strong sell” rating to a “hold” rating in a report on Thursday, October 12th. Finally, Stifel Nicolaus reiterated a “buy” rating on shares of DENTSPLY SIRONA in a report on Thursday, October 19th.

In other news, CFO Nicholas W. Alexos purchased 50,000 shares of the company’s stock in a transaction that occurred on Monday, November 13th. The shares were purchased at an average price of $65.85 per share, for a total transaction of $3,292,500.00. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, Director Eric Brandt sold 6,409 shares of the firm’s stock in a transaction that occurred on Monday, January 8th. The stock was sold at an average price of $68.04, for a total value of $436,068.36. Following the transaction, the director now owns 12,073 shares in the company, valued at approximately $821,446.92. The disclosure for this sale can be found here. Company insiders own 1.99% of the company’s stock.

A number of large investors have recently added to or reduced their stakes in the stock. Stock Yards Bank & Trust Co. purchased a new position in shares of DENTSPLY SIRONA in the 4th quarter valued at approximately $203,000. Atlantic Trust Group LLC grew its stake in shares of DENTSPLY SIRONA by 970.7% in the 3rd quarter. Atlantic Trust Group LLC now owns 475,232 shares of the medical instruments supplier’s stock valued at $28,424,000 after purchasing an additional 430,848 shares during the last quarter. Pura Vida Investments LLC purchased a new position in shares of DENTSPLY SIRONA in the 3rd quarter valued at approximately $9,570,000. Gofen & Glossberg LLC IL grew its stake in shares of DENTSPLY SIRONA by 41.5% in the 3rd quarter. Gofen & Glossberg LLC IL now owns 7,838 shares of the medical instruments supplier’s stock valued at $469,000 after purchasing an additional 2,297 shares during the last quarter. Finally, IFM Investors Pty Ltd purchased a new position in shares of DENTSPLY SIRONA in the 3rd quarter valued at approximately $566,000. Hedge funds and other institutional investors own 96.14% of the company’s stock.

DENTSPLY SIRONA (XRAY) traded up $1.54 during mid-day trading on Wednesday, reaching $65.79. The company’s stock had a trading volume of 1,667,132 shares, compared to its average volume of 1,680,000. The company has a quick ratio of 1.59, a current ratio of 2.32 and a debt-to-equity ratio of 0.21. The firm has a market cap of $15,110.00, a price-to-earnings ratio of -18.91, a P/E/G ratio of 2.36 and a beta of 1.31. DENTSPLY SIRONA has a 52 week low of $52.53 and a 52 week high of $68.98.

DENTSPLY SIRONA (NASDAQ:XRAY) last posted its quarterly earnings results on Friday, November 3rd. The medical instruments supplier reported $0.70 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.66 by $0.04. DENTSPLY SIRONA had a positive return on equity of 7.56% and a negative net margin of 20.33%. The company had revenue of $1.01 billion for the quarter, compared to analyst estimates of $978.99 million. During the same quarter last year, the company earned $0.66 EPS. DENTSPLY SIRONA’s revenue for the quarter was up 5.8% compared to the same quarter last year. equities analysts anticipate that DENTSPLY SIRONA will post 2.65 earnings per share for the current fiscal year.

The company also recently declared a quarterly dividend, which was paid on Friday, January 12th. Investors of record on Friday, December 29th were paid a dividend of $0.0875 per share. The ex-dividend date of this dividend was Thursday, December 28th. This represents a $0.35 dividend on an annualized basis and a yield of 0.53%. DENTSPLY SIRONA’s dividend payout ratio is presently -10.06%.

TRADEMARK VIOLATION NOTICE: “DENTSPLY SIRONA Inc (XRAY) Receives $68.92 Average Price Target from Analysts” was published by Watch List News and is the sole property of of Watch List News. If you are viewing this article on another website, it was stolen and republished in violation of U.S. & international copyright and trademark legislation. The legal version of this article can be accessed at https://www.watchlistnews.com/dentsply-sirona-inc-xray-receives-68-92-average-price-target-from-analysts/1806280.html.

DENTSPLY SIRONA Company Profile

DENTSPLY SIRONA Inc is a manufacturer of professional dental products and technologies. The Company develops, manufactures, and markets solutions offering, including dental and oral health products, as well as other consumable medical devices. It operates through two segments: Dental and Healthcare Consumables, and Technologies.

Analyst Recommendations for DENTSPLY SIRONA (NASDAQ:XRAY)

Receive News & Ratings for DENTSPLY SIRONA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DENTSPLY SIRONA and related companies with MarketBeat.com's FREE daily email newsletter.